Fully automated sample preparation procedure to measure drugs of abuse in plasma by liquid chromatography tandem mass spectrometry. 2018

Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
Department of Pharmacology and Toxicology, Limoges University Hospital, 2 avenue Martin-Luther King, 87042, Limoges, France.

For the analysis of drugs and pharmaceutical compounds in biological matrices, extraction procedures are typically used for LC-MS/MS analysis often requiring manual steps in sample preparation. In this study, we report a fully automated extraction method carried out by a programable liquid handler directly coupled to an LC-MS/MS system for the determination of 42 components (illicit drugs and/or metabolites) (plus 20 deuterated internal standards). The acquisition was performed in positive ionization mode with up to 15 MRM transitions per compound, each with optimized collision energy (MRM spectrum mode) to enable qualitative library searching in addition to quantitation. After placing the sample tube into the system, no further intervention was necessary: automated preparation used 50 μL of blood or plasma with 3 μL of extracted sample injected for analysis. The method was validated according to the requirements of ISO 15189. The limit of detection and quantification was 1-5 ng/mL depending on the compound. Stability experiments found that historic calibration curve data files could accurately quantify for up to 1 month with less than 20% uncertainty. Comparison to a QuEChERS method was made using patient samples providing a regression correlation R2 = 0.98 between the two methods. This approach was successfully designed to support parallel sample preparation and analysis therefore significantly increasing sample throughput and reduced cycle times. Graphical abstract ᅟ.

UI MeSH Term Description Entries
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013287 Illicit Drugs Drugs that are manufactured, obtained, or sold illegally. They include prescription drugs obtained or sold without prescription and non-prescription drugs. Illicit drugs are widely distributed, tend to be grossly impure and may cause unexpected toxicity. Club Drug,Drugs, Illegal,Illegal Drug,Illegal Drugs,Illicit Drug,Recreational Drug,Recreational Drugs,Street Drug,Street Drugs,Club Drugs,Drug, Club,Drug, Illegal,Drug, Illicit,Drug, Recreational,Drug, Street,Drugs, Club,Drugs, Illicit,Drugs, Recreational,Drugs, Street
D015813 Substance Abuse Detection Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection. Drug Abuse Testing,Illicit Drug Testing,Street Drug Testing,Substance Abuse Testing,Drug Abuse Detection,Drug Abuse Screening,Illicit Drug Detection,Street Drug Detection,Detection, Drug Abuse,Detection, Illicit Drug,Detection, Street Drug,Detection, Substance Abuse,Detections, Drug Abuse,Detections, Illicit Drug,Detections, Street Drug,Detections, Substance Abuse,Drug Abuse Detections,Drug Abuse Screenings,Drug Abuse Testings,Drug Testing, Illicit,Drug Testings, Illicit,Illicit Drug Detections,Illicit Drug Testings,Screening, Drug Abuse,Screenings, Drug Abuse,Street Drug Detections,Street Drug Testings,Substance Abuse Detections,Substance Abuse Testings,Testing, Drug Abuse,Testing, Illicit Drug,Testing, Street Drug,Testing, Substance Abuse,Testings, Drug Abuse,Testings, Illicit Drug,Testings, Street Drug,Testings, Substance Abuse
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D057230 Limit of Detection Concentration or quantity that is derived from the smallest measure that can be detected with reasonable certainty for a given analytical procedure. Limits of Detection,Detection Limit,Detection Limits
D018401 Sample Size The number of units (persons, animals, patients, specified circumstances, etc.) in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. (From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p95) Sample Sizes,Size, Sample,Sizes, Sample

Related Publications

Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
January 2023, Journal of mass spectrometry and advances in the clinical lab,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
January 2002, Rapid communications in mass spectrometry : RCM,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
October 1998, Journal of chromatography. A,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
September 2022, Neuropsychopharmacology reports,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
January 1998, Rapid communications in mass spectrometry : RCM,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
January 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
August 2010, Analytical and bioanalytical chemistry,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
May 1987, Journal of chromatography,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
October 2009, Analytical and bioanalytical chemistry,
Tiphaine Robin, and Alan Barnes, and Sylvain Dulaurent, and Neil Loftus, and Sigrid Baumgarten, and Stéphane Moreau, and Pierre Marquet, and Souleiman El Balkhi, and Franck Saint-Marcoux
February 2001, Analytical chemistry,
Copied contents to your clipboard!